NewAmsterdam Pharma Company NV Ordinary Shares
Quarterly Financials
| Values in thousands | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
Revenue | $348 | $19,145 | $2,978 | $12,772 |
Gross Profit | 348 | 19,145 | 2,978 | 12,772 |
EBITDA | -71,941 | -35,590 | -68,873 | -111,693 |
EBIT | -72,005 | -35,635 | -68,925 | -111,744 |
Net Income | -72,005 | -17,364 | -39,527 | -92,177 |
Net Change In Cash | 348 | 19,145 | 2,978 | 12,772 |
Free Cash Flow | -32,811 | -37,759 | -36,484 | -37,484 |
Cash | 538,407 | 563,864 | 748,420 | 771,743 |
Basic Shares | 119,000 | 112,509 | 116,124 | 97,028 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $45,563 | $14,090 | $102,694 | $0 |
Gross Profit | 45,563 | 14,090 | 102,694 | -14 |
EBITDA | -241,486 | -176,861 | -22,338 | -41,369 |
EBIT | -241,599 | -176,910 | -22,347 | -41,374 |
Net Income | -241,598 | -176,937 | -22,634 | -41,785 |
Net Change In Cash | 45,563 | 14,090 | 102,694 | 0 |
Free Cash Flow | -159,236 | -141,242 | 10,444 | -29,536 |
Cash | 771,743 | 340,450 | 467,728 | 60,379 |
Basic Shares | 94,358 | 82,161 | 18,966 | 17,751 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-12-31 | $0 |
2025-09-30 | -$0.53 |
2025-06-30 | -$0.15 |
2025-03-31 | -$0.30 |
